Skip to main content


Page 2 of 17

  1. Injectable opioid agonist treatment (iOAT) has proven to be a safe and effective treatment option for severe opioid use disorder (OUD). Yet, iOAT is often isolated from other health and social services. To ali...

    Authors: Sophia Dobischok, José R. Carvajal, Kyle Turner, Kaitlyn Jaffe, Eisha Lehal, Sarinn Blawatt, Casey Redquest, Rosalind Baltzer Turje, Patrick McDougall, Bryce Koch, Cheryl McDermid, Damon Hassan, Scott Harrison and Eugenia Oviedo-Joekes
    Citation: Addiction Science & Clinical Practice 2023 18:73
  2. Scaling up overdose education and naloxone distribution (OEND), an evidence-based practice for reducing opioid overdose mortality, in communities remains a challenge. Novel models and intentional implementatio...

    Authors: Hannah K. Knudsen, Patricia R. Freeman, Douglas R. Oyler, Carrie B. Oser and Sharon L. Walsh
    Citation: Addiction Science & Clinical Practice 2023 18:72
  3. The harms of opioid use disorder (OUD) and HIV infection disproportionately impact marginalized populations, especially people experiencing homelessness and people who inject drugs (PWID). Mobile OUD service d...

    Authors: Rebecca E. Stewart, Hanna P. Christian, Nicholas C. Cardamone, Catherine Abrams, Caroline Drob, David S. Mandell, David Metzger and Margaret Lowenstein
    Citation: Addiction Science & Clinical Practice 2023 18:71
  4. Preventing progression to moderate or severe opioid use disorder (OUD) among people who exhibit risky opioid use behavior that does not meet criteria for treatment with opioid agonists or antagonists (subthres...

    Authors: Jane M. Liebschutz, Geetha A. Subramaniam, Rebecca Stone, Noa Appleton, Lillian Gelberg, Travis I. Lovejoy, Amanda M. Bunting, Charles M. Cleland, Karen E. Lasser, Donna Beers, Catherine Abrams, Jennifer McCormack, Gail E. Potter, Ashley Case, Leslie Revoredo, Eve M. Jelstrom…
    Citation: Addiction Science & Clinical Practice 2023 18:70
  5. The TAPS Tool (“Tobacco, Alcohol, Prescription drug, and illicit Substance use”) is a screening and brief assessment for detecting unhealthy substance use in healthcare settings that was developed by the National...

    Authors: Jan Gryczynski, Katherine Sanchez, Steven B. Carswell and Robert P. Schwartz
    Citation: Addiction Science & Clinical Practice 2023 18:69
  6. At-risk alcohol use and tobacco smoking often co-occur. We investigated whether brief alcohol interventions (BAIs) among general hospital patients with at-risk alcohol use may also reduce tobacco smoking over ...

    Authors: Filipa Krolo-Wicovsky, Sophie Baumann, Anika Tiede, Gallus Bischof, Ulrich John, Beate Gaertner and Jennis Freyer-Adam
    Citation: Addiction Science & Clinical Practice 2023 18:68

    The Correction to this article has been published in Addiction Science & Clinical Practice 2023 18:74

  7. Acute-care interventions that identify patients with substance use disorders (SUDs), initiate treatment, and link patients to community-based services, have proliferated in recent years. Yet, much is unknown a...

    Authors: Noa Krawczyk, Bianca D. Rivera, Ji E. Chang, Margaux Grivel, Yu-Heng Chen, Suhas Nagappala, Honora Englander and Jennifer McNeely
    Citation: Addiction Science & Clinical Practice 2023 18:67
  8. Tent encampments in the neighborhood surrounding Boston Medical Center (BMC) grew to include 336 individuals at points between 2019 and 21, prompting public health concerns. BMC, the City of Boston, and Common...

    Authors: Miriam Komaromy, Andrea Stone, Alicia Peterson, Jacqueline Gott, Rob Koenig and Jessica L. Taylor
    Citation: Addiction Science & Clinical Practice 2023 18:66
  9. Approximately 50% of the patients who globally seek help in psychiatry have been assessed with problematic substance use or been diagnosed with substance use disorder (SUD). Given the high treatment gap for me...

    Authors: Elisabeth Petersén, Hanna Augustsson and Anne H. Berman
    Citation: Addiction Science & Clinical Practice 2023 18:65
  10. The Health of the Nation Outcome Scale (HoNOS) is a widely used 12-item tool to assess mental health and social functioning. The French version has an added 13th item measuring adherence to psychotropic medica...

    Authors: Anne Chatton, Yasser Khazaal and Louise Penzenstadler
    Citation: Addiction Science & Clinical Practice 2023 18:64
  11. Client discontinuation from outpatient addiction treatment programs is common, and the initial intake is the service delivery point with the highest attrition rate. Replacing the comprehensive intake assessmen...

    Authors: Margo C. Hurlocker, Theresa B. Moyers, Melissa Hatch, Geoffrey Curran, Barbara McCrady, Kamilla L. Venner and Katie Witkiewitz
    Citation: Addiction Science & Clinical Practice 2023 18:63
  12. GHB (gammahydroxybutyrate) and its precursors are popular recreational drugs due to their sedative, anxiolytic and sexually stimulating effects. Their use has been steadily increasing in recent years. The deto...

    Authors: Peter Neu, Heidi Danker-Hopfe, Robert Fisher and Felicitas Ehlen
    Citation: Addiction Science & Clinical Practice 2023 18:62
  13. During the COVID-19 pandemic, federal regulations in the USA for methadone treatment of opioid use disorder (OUD) were temporarily revised to reduce clinic crowding and promote access to treatment.

    Authors: Shannon Gwin Mitchell, Julia Jester, Jan Gryczynski, Melanie Whitter, Douglas Fuller, Caroline Halsted and Robert P. Schwartz
    Citation: Addiction Science & Clinical Practice 2023 18:61
  14. Oral antiretroviral therapy (ART) has been effective at reducing mortality rates of people with HIV. However, despite its effectiveness, people who use drugs face barriers to maintaining ART adherence. Receipt...

    Authors: Kirsten J. Langdon, Anthony E. Hitch, Alexandra B. Collins, Curt G. Beckwith, Sara Becker, Karen Tashima and Josiah D. Rich
    Citation: Addiction Science & Clinical Practice 2023 18:60
  15. The time after contact with specialized health services for mental health and substance use is associated with an increased risk of suicide, where temporal aspects of suicide and comorbid mental disorders in p...

    Authors: Martin Ø. Myhre, Fredrik A. Walby, Jørgen G. Bramness and Lars Mehlum
    Citation: Addiction Science & Clinical Practice 2023 18:59
  16. Youth, 18 to 24 years, experiencing homelessness (YEH) are recognized as having developmental challenges dissimilar to older adults. Yet, research on efforts to end homelessness and prevent or intervene in dru...

    Authors: Natasha Slesnick, Brittany Brakenhoff, Alicia Bunger, Laura Chavez, Caleb Cuthbertson, Ruri Famelia, Xin Feng, Maggie Fitzpatrick, Jodi Ford, Irene Hatsu, Eugene Holowacz, Soren Jaderlund, Kelly Kelleher, Ellison Luthy, Allen Mallory, Jared Martin…
    Citation: Addiction Science & Clinical Practice 2023 18:58
  17. Recovery from substance use is commonly seen as a process of integrating social relationships and creating a sense of meaning in one’s life. Dog owners describe a close relationship with their dog that impacts...

    Authors: Andi Kerr-Little, Jørgen G. Bramness, Ruth C. Newberry and Stian Biong
    Citation: Addiction Science & Clinical Practice 2023 18:57
  18. Screening for substance use in rural primary care clinics faces unique challenges due to limited resources, high patient volumes, and multiple demands on providers. To explore the potential for electronic heal...

    Authors: Jennifer McNeely, Bethany McLeman, Trip Gardner, Noah Nesin, Vijay Amarendran, Sarah Farkas, Aimee Wahle, Seth Pitts, Margaret Kline, Jacquie King, Carmen Rosa, Lisa Marsch, John Rotrosen and Leah Hamilton
    Citation: Addiction Science & Clinical Practice 2023 18:56
  19. Alcohol use disorder (AUD) commonly causes hospitalization, particularly for individuals disproportionately impacted by structural racism and other forms of marginalization. The optimal approach for engaging h...

    Authors: E. Jennifer Edelman, Oscar F. Rojas-Perez, Charla Nich, Joanne Corvino, Tami Frankforter, Derrick Gordon, Ayana Jordan, Manuel Paris, Jr, Melissa B. Weimer, Brian T. Yates, Emily C. Williams and Brian D. Kiluk
    Citation: Addiction Science & Clinical Practice 2023 18:55
  20. Opioid overdoses have continued to increase since the start of the COVID-19 pandemic. The pathways through which the COVID-19 pandemic has affected trajectories of opioid use and opioid-related problems are la...

    Authors: Tim Janssen, Bryan R. Garner, Julia Yermash, Kimberly R. Yap and Sara J. Becker
    Citation: Addiction Science & Clinical Practice 2023 18:54
  21. Substance use in women is associated with unique psycho-social and physical vulnerabilities and poses complex challenges during pregnancy and motherhood. Gender-sensitive drug policy which considers the needs ...

    Authors: Abhishek Ghosh, Dijana Jerkovic, Liljana Aleksandar Ignjatova, Carla Bruguera, Dalia I. Ibrahim, Katarzyna Okulicz-Kozaryn, J. Maphisa Maphisa, Thomas F. Martinelli, Ana Neto, Joana Canedo and Rebecca Gordon
    Citation: Addiction Science & Clinical Practice 2023 18:53
  22. Research suggests peer support groups can amplify and extend treatment effects and enhance long-term recovery from Alcohol and Other Drug (AOD) problems. However, they are rarely integrated into outpatient tre...

    Authors: V. Manning, A. D. Roxburgh and M. Savic
    Citation: Addiction Science & Clinical Practice 2023 18:52
  23. We use a novel, longitudinal approach to describe average time spent in opioid use disorder (OUD) cascade of care stages for people with HIV (PWH) and with OUD, incorporating four definitions of treatment rete...

    Authors: Jarratt D. Pytell, Anthony T. Fojo, Jeanne C. Keruly, LaQuita N. Snow, Oluwaseun Falade-Nwulia, Richard D. Moore, Geetanjali Chander and Catherine R. Lesko
    Citation: Addiction Science & Clinical Practice 2023 18:51
  24. In studies of the general population and of military veterans, many primary care patients with hazardous drinking and PTSD and/or depression (abbreviated here as HD +) do not initiate or engage with alcohol-re...

    Authors: Michael A. Cucciare, Kathy Marchant, Cristy Benton, Deanna Hildebrand, Sharfun Ghaus, Xiaotong Han, Ronald G. Thompson and Christine Timko
    Citation: Addiction Science & Clinical Practice 2023 18:50
  25. A valid opioid use disorder (OUD) identification algorithm for use in administrative medical record data would enhance investigators’ ability to study consequences of OUD, OUD treatment seeking and treatment o...

    Authors: Jeffrey F. Scherrer, Mark D. Sullivan, Marc R. LaRochelle and Richard Grucza
    Citation: Addiction Science & Clinical Practice 2023 18:49
  26. An emerging public health threat of methamphetamine/opioid co-use is occurring in North America, including increases in overdoses related to concomitant methamphetamine/opioid use. This presents a potential ri...

    Authors: Cayley Russell, Justine Law, Sameer Imtiaz, Jürgen Rehm, Bernard Le Foll and Farihah Ali
    Citation: Addiction Science & Clinical Practice 2023 18:48
  27. We examined acceptability of and preferences for potential medications for treating methamphetamine use disorder (MUD) among people who use methamphetamine and examined how benefits and drawbacks of methamphet...

    Authors: Karla D. Wagner, Charles Marks, Phillip Fiuty, Robert W. Harding and Kimberly Page
    Citation: Addiction Science & Clinical Practice 2023 18:47
  28. A minority of all individuals with alcohol use disorders (AUD) seek treatment, where stigma is one prominent barrier. Social support is important to facilitate health and increase treatment-seeking. Whether th...

    Authors: Sara Wallhed Finn, Anna Mejldal and Anette Søgaard Nielsen
    Citation: Addiction Science & Clinical Practice 2023 18:46
  29. Pharmacy administration and dispensing of methadone treatment for opioid use disorder (PADMOUD) may address inadequate capability of opioid treatment programs (OTPs) in the US by expanding access to methadone ...

    Authors: Li-Tzy Wu, William S. John, Paolo Mannelli, Eric D. Morse, Alyssa Anderson and Robert P. Schwartz
    Citation: Addiction Science & Clinical Practice 2023 18:45
  30. Motivational enhancement therapy (MET) has shown to be efficacious as treatment of alcohol use disorder (AUD), in reducing alcohol consumption and related consequences. However, qualitative research on how pat...

    Authors: Stina Ingesson Hammarberg, Jennie Sundbye, Rebecca Tingvall, Anders Hammarberg and Christina Nehlin
    Citation: Addiction Science & Clinical Practice 2023 18:44
  31. Use of benzodiazepines (BZD) in patients receiving opioid agonist treatment (OAT) is common and associated with a variety of negative health and social outcomes. This cross-sectional study investigates the imp...

    Authors: Maximilian Meyer, Ferdinand Gygli, Jean N. Westenberg, Otto Schmid, Johannes Strasser, Undine E. Lang, Kenneth M. Dürsteler and Marc Vogel
    Citation: Addiction Science & Clinical Practice 2023 18:43
  32. Acute care inpatient admissions outside of psychiatric facilities have been increasingly identified as a critical touchpoint for opioid use disorder (OUD) treatment. We sought to describe non-opioid overdose h...

    Authors: Sudha R. Raman, Cassie B. Ford, Bradley G. Hammill, Amy G. Clark, Dana C. Clifton and George L. Jackson
    Citation: Addiction Science & Clinical Practice 2023 18:42
  33. Extant literature is limited on adoption of evidence-based harm reduction strategies in hospitals. We explored patient perceptions of incorporating harm reduction supplies and education in hospital care with p...

    Authors: Rachel French, M. Holliday Davis, Shoshana V. Aronowitz, Molly Crowe, Matthew Abrams, Grace Edwards and Margaret Lowenstein
    Citation: Addiction Science & Clinical Practice 2023 18:41
  34. Syringe services programs (SSPs) provide a spectrum of health services to people who use drugs, with many providing referral and linkage to substance use disorder (SUD) treatment, and some offering co-located ...

    Authors: Andrea Jakubowski, Sabrina Fowler and Aaron D. Fox
    Citation: Addiction Science & Clinical Practice 2023 18:40
  35. Breaking Free Online (BFO), a computer-assisted therapy (CAT) program for substance use disorders (SUD), has been available across UK treatment services for the past decade and has demonstrated efficacy. The C...

    Authors: Sarah Elison-Davies, Lauren Pittard, Tracey Myton, Andrew Jones, Jonathan Ward and Glyn Davies
    Citation: Addiction Science & Clinical Practice 2023 18:39
  36. Hospitalizations are a vital opportunity for the initiation of life-saving opioid agonist therapy (OAT) for patients with opioid use disorder. A novel approach to OAT initiation is the use of IV buprenorphine ...

    Authors: John P. Murray, Geoffrey Pucci, George Weyer, Mim Ari, Sarah Dickson and Angela Kerins
    Citation: Addiction Science & Clinical Practice 2023 18:38
  37. Individuals who have substance use disorders may have an elevated risk of suicidality. This study sought to examine the prevalence of, and identify factors associated with, suicidality in adults with opioid us...

    Authors: Michelle R. Lent, Karen L. Dugosh, Emily Hurstak, Hannah R. Callahan and Kimberly Mazur
    Citation: Addiction Science & Clinical Practice 2023 18:37
  38. Music therapy has been shown to be effective for multiple clinical endpoints associated with substance use disorder such as craving reduction, emotion regulation, depression, and anxiety, but there are a lack ...

    Authors: Jörg Fachner, Clemens Maidhof, Daniel Murtagh, Devon De Silva, Filippo Pasqualitto, Paul Fernie, Francesca Panin, Andrew Michell, Leonardo Muller-Rodriguez and Helen Odell-Miller
    Citation: Addiction Science & Clinical Practice 2023 18:36
  39. Hepatitis C virus (HCV) transmission is primarily driven by injection drug use, and acute HCV infection rates are increased in rural communities with substantial barriers to care. Treatment of HCV in persons w...

    Authors: Megan C. Herink, Andrew Seaman, Gillian Leichtling, Jessica E. Larsen, Tonhi Gailey, Ryan Cook, Ann Thomas and P. Todd Korthuis
    Citation: Addiction Science & Clinical Practice 2023 18:35
  40. Concomitant with low rates of pharmacotherapy for incarcerated individuals with OUD, there is a high rate of opioid overdose following re-entry into the community. Our research objective was to develop a bette...

    Authors: Techna Cadet, Ali Jalali, Philip J. Jeng, Sabrina Poole, George Woody and Sean M. Murphy
    Citation: Addiction Science & Clinical Practice 2023 18:34
  41. This study examined associations between receipt of hepatitis C (HCV) treatment and retention in office-based opioid treatment (OBOT) care.

    Authors: Mary L. Geist, Andrea C. Radick, Judith I. Tsui, Kendra L. Blalock, Addy Adwell, Elsabeth Tamru, Nancy C. Connolly and Jocelyn R. James
    Citation: Addiction Science & Clinical Practice 2023 18:33
  42. Smokeless tobacco (SLT) products are gaining popularity around the globe, particularly in Asia, Africa, and the Middle East. Among these products, Nass (aka Naswar) is popular among the Turkmen ethnicity in Ir...

    Authors: Bagher Pahlavanzadeh, Shohreh Kolagari, Mohammad Ebrahimi Kalan, Ziyad Ben Taleb, Kenneth D. Ward, Samane Zare and Abdurrahman Charkazi
    Citation: Addiction Science & Clinical Practice 2023 18:32
  43. Hospital-based clinicians infrequently initiate medications for opioid use disorder (MOUD) for hospitalized patients. Our objective was to understand hospital-based clinicians’ knowledge, comfort, attitudes, a...

    Authors: Andrea Jakubowski, Sumeet Singh-Tan, Kristine Torres-Lockhart, Shadi Nahvi, Melissa Stein, Aaron D. Fox and Tiffany Lu
    Citation: Addiction Science & Clinical Practice 2023 18:31
  44. SMART (Self-Management and Recovery Training) Recovery is a mutual-aid program informed by cognitive behaviour therapy and motivational interviewing that provides support for a range of addictive behaviours. S...

    Authors: Alistair Lum, Despoina Damianidou, Kylie Bailey, Stephanie Cassel, Katherine Unwin, Alison Beck, Peter J. Kelly, Angela Argent, Frank P. Deane, Sophie Langford, Amanda L. Baker and Kristen McCarter
    Citation: Addiction Science & Clinical Practice 2023 18:30
  45. Approximately 400,000 people who smoke cigarettes survive Acute Coronary Syndrome (ACS; unstable angina, ST and non-ST elevation myocardial infarction) each year in the US. Continued smoking following ACS is a...

    Authors: Melissa Adkins-Hempel, Sandra J. Japuntich, Michelle Chrastek, Shira Dunsiger, Christopher E. Breault, Woubeshet Ayenew, Susan A. Everson-Rose, Prabhjot S. Nijjar, Beth C. Bock, Wen-Chih Wu, Michael D. Miedema, Brett M. Carlson and Andrew M. Busch
    Citation: Addiction Science & Clinical Practice 2023 18:29
  46. Although the detrimental health effects of alcohol are well established, consumption levels are high in many high-income countries such as Germany. Improving alcohol health literacy presents an integrated appr...

    Authors: Jakob Manthey, Daša Kokole, Steffi Riedel-Heller, Gill Rowlands, Ingo Schäfer, Georg Schomerus, Renate Soellner and Carolin Kilian
    Citation: Addiction Science & Clinical Practice 2023 18:28
  47. Alcohol use disorders (AUD) are prevalent and often go untreated. Patients are commonly screened for AUD in primary care, but existing treatment programs are failing to meet demand. Digital therapeutics includ...

    Authors: Jessica M. Mogk, Theresa E. Matson, Ryan M. Caldeiro, Angela M. Garza Mcwethy, Tara Beatty, Brandie C. Sevey, Clarissa W. Hsu and Joseph E. Glass
    Citation: Addiction Science & Clinical Practice 2023 18:27
  48. Most people with opioid use disorder (OUD) have co-occurring substance use, which is associated with lower receipt of OUD medications (MOUD). Expanding MOUD provision and care linkage outside of substance use ...

    Authors: Madeline C. Frost, Elena M. Soyer, Carol E. Achtmeyer, Eric J. Hawkins, Joseph E. Glass, Kevin A. Hallgren and Emily C. Williams
    Citation: Addiction Science & Clinical Practice 2023 18:26
  49. Individuals with substance use disorder (SUD) have high prevalence of cigarette smoking and difficulty quitting. Peer recovery coaches (PRCs; individuals with lived SUD experience) facilitate SUD behavior chan...

    Authors: Joanna M. Streck, Susan Regan, Michael Werner, Alexia Glynn, Andrea C. Villanti, Elyse R. Park, Sarah E. Wakeman, A. Eden Evins and Nancy A. Rigotti
    Citation: Addiction Science & Clinical Practice 2023 18:25
  50. National opioid-related overdose fatalities totaled 650,000 from 1999 to 2021. Some of the highest rates occurred in New Hampshire, where 40% of the population lives rurally. Medications for opioid use disorde...

    Authors: Owen B. Murray, Marcy Doyle, Bethany M. McLeman, Lisa A. Marsch, Elizabeth C. Saunders, Katherine M. Cox, Delitha Watts and Jeanne Ryer
    Citation: Addiction Science & Clinical Practice 2023 18:24

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    3.7 - 2-year Impact Factor
    4.4 - 5-year Impact Factor
    0.956 - SNIP (Source Normalized Impact per Paper)
    1.166 - SJR (SCImago Journal Rank)

    2023 Speed
    25 days submission to first editorial decision for all manuscripts (Median)
    202 days submission to accept (Median)

    2023 Usage 
    622 Altmetric mentions

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.